We present the total synthesis of macrocyclic analogues of the immunomodulating glycolipid α‐GalCer (KRN7000), along with the corresponding macrocyclic aglycons. Their structures are inspired by the conformation of α‐GalCer when bound to the antigen presenting glycoprotein CD1d. The applied synthesis plan, involving either ring‐closing metathesis or ruthenium‐catalyzed azide‐alkyne cycloaddition for the crucial macrocyclization step, allowed for easy alteration of the ring size of the macrocycles. These compounds constitute a series of novel cyclic glycosphingolipid analogues
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
A library of dimeric CD1d ligands, containing two α-galactosyl ceramide (α-GalCer) units linked by s...
Le sujet de thèse concerne l’immunothérapie induite par des glycolipides synthétiques dont le chef ...
We present the total synthesis of macrocyclic analogues of the immunomodulating glycolipid α‐GalCer ...
Novel strategies for the synthesis of structurally complex macrocyclic glycolipids are outlined whic...
Novel strategies for the synthesis of structurally complex macrocyclic glycolipids are outlined whic...
Le KRN 7000 a une action antitumorale due à la stimulation du système immunitaire. Il agit sur les m...
KRN7000 anti-tumor activity is due to immune system stimulation. It acts on autoimmunes diseases, ba...
KRN7000 anti-tumor activity is due to immune system stimulation. It acts on autoimmunes diseases, ba...
A new practical synthesis of alpha-GalCer and of its analogues is presented, opening the chance to e...
Unique types of ceramide and glycolipid architectures were obtained by means of Ugi reactions incorp...
<p></p> <p>A focused library of novel <i>N</i>-alkyl-2-pyrrolidinone derivatives <b>3a–e</b> was syn...
Key reactions in a concise synthesis of an α-C-galactosylceramide analogue of KRN7000 include a dias...
NKT cells, a unique subset of T cells that recognizes glycolipid antigens presented by CD1d molecule...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
A library of dimeric CD1d ligands, containing two α-galactosyl ceramide (α-GalCer) units linked by s...
Le sujet de thèse concerne l’immunothérapie induite par des glycolipides synthétiques dont le chef ...
We present the total synthesis of macrocyclic analogues of the immunomodulating glycolipid α‐GalCer ...
Novel strategies for the synthesis of structurally complex macrocyclic glycolipids are outlined whic...
Novel strategies for the synthesis of structurally complex macrocyclic glycolipids are outlined whic...
Le KRN 7000 a une action antitumorale due à la stimulation du système immunitaire. Il agit sur les m...
KRN7000 anti-tumor activity is due to immune system stimulation. It acts on autoimmunes diseases, ba...
KRN7000 anti-tumor activity is due to immune system stimulation. It acts on autoimmunes diseases, ba...
A new practical synthesis of alpha-GalCer and of its analogues is presented, opening the chance to e...
Unique types of ceramide and glycolipid architectures were obtained by means of Ugi reactions incorp...
<p></p> <p>A focused library of novel <i>N</i>-alkyl-2-pyrrolidinone derivatives <b>3a–e</b> was syn...
Key reactions in a concise synthesis of an α-C-galactosylceramide analogue of KRN7000 include a dias...
NKT cells, a unique subset of T cells that recognizes glycolipid antigens presented by CD1d molecule...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
A library of dimeric CD1d ligands, containing two α-galactosyl ceramide (α-GalCer) units linked by s...
Le sujet de thèse concerne l’immunothérapie induite par des glycolipides synthétiques dont le chef ...